Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells.

Chinese hamster ovary and murine myeloma NS0 cells are currently favored host cell types for the production of therapeutic recombinant proteins. In this study, we compared N-glycan processing in GS-NS0 and GS-CHO cells producing the same model recombinant glycoprotein, tissue inhibitor of metalloproteinases 1. By manipulation of intracellular nucleotide-sugar content, we examined the feasibility of implementing metabolic control strategies aimed at reducing the occurrence of murine-specific glycan motifs on NS0-derived recombinant proteins, such as Galalpha1,3Galbeta1,4GlcNAc. Although both CHO and NS0-derived oligosaccharides were predominantly of the standard complex type with variable sialylation, 30% of N-glycan antennae associated with NS0-derived TIMP-1 terminated in alpha1,3-linked galactose residues. Furthermore, NS0 cells conferred a greater proportion of terminal N-glycolylneuraminic (sialic) acid residues as compared with the N-acetylneuraminic acid variant. Inclusion of the nucleotide-sugar precursors, glucosamine (10 mM, plus 2 mM uridine) and N-acetylmannosamine (20 mM), in culture media were shown to significantly increase the intracellular pools of UDP-N-acetylhexosamine and CMP-sialic acid, respectively, in both NS0 and CHO cells. The elevated UDP-N-acetylhexosamine content induced by the glucosamine/uridine treatment was associated with an increase in the antennarity of N-glycans associated with TIMP-1 produced in CHO cells but not N-glycans associated with TIMP-1 from NS0 cells. In addition, elevated UDP-N-acetylhexosamine content was associated with a slight decrease in sialylation in both cell lines. The elevated CMP-sialic acid content induced by N-acetylmannosamine had no effect on the overall level of sialylation of TIMP-1 produced by both CHO and NS0 cells, although the ratio of N-glycolylneuraminic acid:N-acetylneuraminic acid associated with NS0-derived TIMP-1 changed from 1:1 to 1:2. These data suggest that manipulation of nucleotide-sugar metabolism can promote changes in N-glycan processing that are either conserved between NS0 and CHO cells or specific to either NS0 cells or CHO cells.

[1]  R. Knop,et al.  Role of Nucleotide Sugar Pools in the Inhibition of NCAM Polysialylation by Ammonia , 1998, Biotechnology progress.

[2]  A. Edge,et al.  ENZYMATIC REMOVAL OF ALPHA‐GALACTOSYL EPITOPES FROM PORCINE ENDOTHELIAL CELLS DIMINISHES THE CYTOTOXIC EFFECT OF NATURAL ANTIBODIES , 1995, Transplantation.

[3]  B K Hayes,et al.  O-GlcNAcylation of key nuclear and cytoskeletal proteins: reciprocity with O-phosphorylation and putative roles in protein multimerization. , 1996, Glycobiology.

[4]  R. Wagner,et al.  Incorporation of ammonium into intracellular UDP-activated N-acetylhexosamines and into carbohydrate structures in glycoproteins. , 1999, Biotechnology and bioengineering.

[5]  E. Salvaris,et al.  Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice. , 1997, Transplantation.

[6]  R. Dwek,et al.  Oligosaccharide sequencing technology , 1997, Nature.

[7]  C. Goochee,et al.  Characterization of the glycosylation of a human IgM produced by a human-mouse hybridoma. , 1995, Glycobiology.

[8]  Bernard Thorens,et al.  Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion , 1986, Nature.

[9]  J. Vliegenthart,et al.  Structural analysis of the sialylated N- and O-linked carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Sialylation patterns and branch location of dimeric N-acetyllactosamine units. , 1995, European journal of biochemistry.

[10]  R. Gerardy-Schahn,et al.  Molecular cloning of the hamster CMP-sialic acid transporter. , 1997, European journal of biochemistry.

[11]  M. Gilbert,et al.  Characterization of a Recombinant Neisseria Meningitidesα-2,3-Sialyltransferase and its Acceptor Specificity , 1997 .

[12]  M Ohlin,et al.  Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics? , 1993, Immunology today.

[13]  C. Hirschberg.  Transporters of nucleotide sugars, nucleotide sulfate and ATP in the Golgi apparatus membrane: Where next? , 1997, Glycobiology.

[14]  P. Stanley,et al.  Mammalian cytidine 5'-monophosphate N-acetylneuraminic acid synthetase: a nuclear protein with evolutionarily conserved structural motifs. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M J Keen,et al.  Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. , 1995, Glycobiology.

[16]  M. Naiki,et al.  Immunogenicity of N-glycolylneuraminic acid-containing carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. , 1995, Journal of biochemistry.

[17]  R. Sitia,et al.  Differential expression of Galα1,3Gal epitope in polymeric and monomeric IgM secreted by mouse myeloma cells deficient in α2,6-sialyltransferase , 1998 .

[18]  R. Wagner,et al.  Intracellular UDP−N‐Acetylhexosamine Pool Affects N‐Glycan Complexity: A Mechanism of Ammonium Action on Protein Glycosylation , 1998, Biotechnology progress.

[19]  G. Hart,et al.  Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase. , 1992, The Journal of biological chemistry.

[20]  A. Varki,et al.  Biosynthesis of N-glycolyneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool. , 1989, The Journal of biological chemistry.

[21]  R. Dwek,et al.  Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. , 1997, Biochemistry.

[22]  Daniel I. C. Wang,et al.  Improvement of interferon-gamma sialylation in Chinese hamster ovary cell culture by feeding of N-acetylmannosamine. , 1998, Biotechnology and bioengineering.

[23]  R. Huber,et al.  Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 , 1997, Nature.

[24]  R. Cummings,et al.  A Soluble Form of α1,3-Galactosyltransferase Functions within Cells to Galactosylate Glycoproteins* , 1997, The Journal of Biological Chemistry.

[25]  D. James,et al.  N-Glycosylation of Recombinant Human Interferon-γ Produced in Different Animal Expression Systems , 1995, Bio/Technology.

[26]  R. Jefferis,et al.  Glycosylation of antibody molecules: structural and functional significance. , 1996, Chemical immunology.

[27]  J. F. Koerner.  Enzymes of nucleic acid metabolism. , 1970, Annual review of biochemistry.

[28]  J. Lofgren,et al.  Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins , 1999, Nature Biotechnology.

[29]  R. Wagner,et al.  Ammonium ion and glucosamine dependent increases of oligosaccharide complexity in recombinant glycoproteins secreted from cultivated BHK-21 cells. , 1998, Biotechnology and bioengineering.

[30]  M. Radic,et al.  One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. , 1993, Blood.

[31]  M. Ito,et al.  Functional expression of human golgi CMP-sialic acid transporter in the Golgi complex of a transporter-deficient Chinese hamster ovary cell mutant. , 1998, Journal of biochemistry.

[32]  A. Suzuki,et al.  CMP-N-Acetylneuraminic acid hydroxylase is exclusively inactive in humans. , 1998, Biochemical and biophysical research communications.

[33]  D. Keppler,et al.  D-glucosamine-induced changes in nucleotide metabolism and growth of colon-carcinoma cells in culture. , 1984, The Biochemical journal.

[34]  T. Raju,et al.  Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. , 2000, Glycobiology.

[35]  Gregory Stephanopoulos,et al.  Metabolic effects on recombinant interferon‐γ glycosylation in continuous culture of Chinese hamster ovary cells , 1999 .

[36]  B. André,et al.  Cloning and expression of the MEP1 gene encoding an ammonium transporter in Saccharomyces cerevisiae. , 1994, The EMBO journal.

[37]  W. Reutter,et al.  A Bifunctional Enzyme Catalyzes the First Two Steps in N-Acetylneuraminic Acid Biosynthesis of Rat Liver , 1997, The Journal of Biological Chemistry.

[38]  D. James,et al.  Analysis of N -Glycans by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry , 1997 .

[39]  D. Carey,et al.  CMP-N-Acetylneuraminic acid: Isolation from and penetration into mouse liver microsomes , 1980, Cell.

[40]  A R Flesher,et al.  Fluorophore‐labeled carbohydrate analysis of immunoglobulin fusion proteins: Correlation of oligosaccharide content with in vivo clearance profile , 1995, Biotechnology and bioengineering.

[41]  A. Bull,et al.  Monitoring recombinant human interferon‐gamma N‐glycosylation during perfused fluidized‐bed and stirred‐tank batch culture of CHO cells , 1998, Biotechnology and bioengineering.

[42]  L. Taylor,et al.  Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose. , 1997, Analytical biochemistry.

[43]  J. Briggs,et al.  A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. , 1998, Glycobiology.

[44]  R. Cummings,et al.  Transfer and expression of a murine UDP-Gal:beta-D-Gal-alpha 1,3-galactosyltransferase gene in transfected Chinese hamster ovary cells. Competition reactions between the alpha 1,3-galactosyltransferase and the endogenous alpha 2,3-sialyltransferase. , 1990, The Journal of biological chemistry.

[45]  Nigel Jenkins,et al.  Getting the glycosylation right: Implications for the biotechnology industry , 1996, Nature Biotechnology.

[46]  E. De Clercq,et al.  Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation. , 1999, Biochemical pharmacology.

[47]  D. James,et al.  Constraints on the transport and glycosylation of recombinant IFN-gamma in Chinese hamster ovary and insect cells. , 1999, Biotechnology and bioengineering.

[48]  A. Kobata,et al.  Elucidation of the phenotypic change on the surface of Had-1 cell, a mutant cell line of mouse FM3A carcinoma cells selected by resistance to Newcastle disease virus infection. , 1989, Journal of biochemistry.

[49]  James E. Bailey,et al.  Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity , 1999, Nature Biotechnology.

[50]  R. Schnaar,et al.  Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells. , 2000, Glycobiology.

[51]  R. Parekh,et al.  Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. , 1995, Analytical biochemistry.

[52]  M. Cockett,et al.  High Level Expression of Tissue Inhibitor of Metalloproteinases in Chinese Hamster Ovary Cells Using Glutamine Synthetase Gene Amplification , 1990, Bio/Technology.

[53]  C W Sutton,et al.  Site-specific characterization of glycoprotein carbohydrates by exoglycosidase digestion and laser desorption mass spectrometry. , 1994, Analytical biochemistry.

[54]  R. Gerardy-Schahn,et al.  Functional Expression of the Murine Golgi CMP-Sialic Acid Transporter in Saccharomyces cerevisiae * , 1997, The Journal of Biological Chemistry.

[55]  M. Kawakita,et al.  Nucleotide sugar transporters: elucidation of their molecular identity and its implication for future studies. , 1998, Journal of biochemistry.

[56]  C. Goochee,et al.  The effect of ammonia on the O‐linked glycosylation of granulocyte colony‐stimulating factor produced by chinese hamster ovary cells , 1995, Biotechnology and bioengineering.

[57]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[58]  R. Gerardy-Schahn,et al.  Expression cloning of the Golgi CMP-sialic acid transporter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Dwek,et al.  A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. , 1996, Analytical biochemistry.

[60]  T. Ryll,et al.  Biochemistry of growth inhibition by ammonium ions in mammalian cells , 1994, Biotechnology and bioengineering.

[61]  B Overdijk,et al.  The effect of increasing nucleotide-sugar concentrations on the incorporation of sugars into glycoconjugates in rat hepatocytes. , 1995, The Biochemical journal.